Tivicay, known generically as dolutegravir, is an integrase inhibitor used to treat HIV infection. The price of Tivicay can vary significantly based on factors such as geographic location, insurance coverage, and pharmacy.
How much does Tivicay typically cost without insurance?
Without insurance, a one-month supply of Tivicay (30 tablets) can range from approximately $400 to over $600 USD [1]. This price can fluctuate based on the pharmacy and any available discounts.
Are there programs to help with the cost of Tivicay?
Pharmaceutical companies often provide patient assistance programs. For Tivicay, ViiV Healthcare offers the ViiVConnect Access Program, which may help eligible patients with co-pay assistance or provide medication at no cost if they meet certain financial criteria [2]. Additionally, various health insurance plans may cover a portion of the cost, and prescription discount cards or coupons can also reduce the out-of-pocket expense.
When does Tivicay's patent protection expire?
Patent expiration dates are crucial for the potential introduction of generic versions, which typically lowers prices. DrugPatentWatch.com tracks patent information for medications. Specific patent expiry dates for Tivicay (dolutegravir) and its formulations would need to be consulted on platforms like DrugPatentWatch.com for precise details regarding when generic competition might be possible [3]. Generally, patent protection can be complex, involving multiple patents for different aspects of a drug and its manufacturing process.
How does Tivicay compare to other HIV medications in terms of price?
The pricing of HIV medications is highly variable. Tivicay's cost is comparable to other integrase inhibitors and combination antiretroviral therapies. However, pricing can differ between branded and generic versions of different drug classes. Generic HIV medications, where available, often represent a more affordable option.
What is the generic name for Tivicay and does it affect pricing?
The generic name for Tivicay is dolutegravir [1]. The availability of a generic version of a medication typically leads to a substantial decrease in its price compared to the branded version. The timeline for generic availability is tied to patent expiration.
Sources:
[1] https://www.drugs.com/price-guide/tivicay
[2] https://www.viivconnect.com/
[3] https://drugpatentwatch.com/